Sun Pharmaceutical Industries Limited vs Zenotech Laboratories Ltd

A side-by-side comparison of Sun Pharmaceutical Industries Limited (SUNPHARMA) and Zenotech Laboratories Ltd (ZENOTECH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Limited leads SUNPHARMA vs ZENOTECH on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth10
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.46
P/E ratio
-108.90
5.35
P/B ratio
2.87
0.86%
Dividend yield
0.00%
₹47.80
EPS
₹-0.18

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

13.74%
Return on equity
-1.13%
17.46%
Return on capital
4.40%
30.33%
EBITDA margin
12.98%
19.69%
Net margin
-2.71%

Growth

SUNPHARMA takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
-2.30%
10.57%
Profit CAGR (3Y) even
—

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.19L Cr
Market cap
₹262 Cr
₹58,462 Cr
Revenue
₹40 Cr
₹11,509 Cr
Net profit
₹-1 Cr
0.06
Debt / equity
0.00
Sun Pharmaceutical Industries Limited
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.00 times its book value"]
Zenotech Laboratories Ltd
  • + ["Company is almost debt free."]
  • − ["Company has a low return on equity of 4.8% over last 3 years.", "Company reported a net loss of ₹1 Cr in its latest financial year."]
Sun Pharmaceutical Industries Limited full analysis Zenotech Laboratories Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.